| ABNMP | alpha-benzyl-N-methyl phenethylamine |
|---|---|
| ALME | acetyl-lysine methyl ester |
| AME | amphotericin methyl ester; apparent minerallocorticoid excess; aseptic meningoencephalitis |
| AMPA | alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate; American Medical Publishers Association |
| BAME | benzoylarginine methyl ester |
| methyl salicylate | Aromatic methyl ester of salicylic acid, produced synthetically or distilled from Gaultheria procumbens (family Ericaceae) or from Betula lenta (family Betulaceae). Used as a component of liniments, used externally and internally for the treatment of various forms of rheumatismit produces heat when rubbed into the skin (counterirritant). Synonym: checkerberry oil, gaultheria oil, sweet birch oil, wintergreen oil. (05 Mar 2000) |
|---|---|
| methyl sterol oxidase | <enzyme> Converts sterol 4-methyl to carboxylic acid; requires NADH or NADPH Registry number: EC 1.- Synonym: methyl sterol mixed function oxidase, 4-methyl sterol oxidase, methylsterol oxidase, 4alpha-methylsterol oxidase (26 Jun 1999) |
| methyl sulfoxide reductase | <enzyme> Reduces methyl sulfoxide group to methyl sulfide on various xenobiotics Registry number: EC 1.8.99.- Synonym: methyl sulfoxide reductase I, methyl sulfoxide reductase II (26 Jun 1999) |
| methyl-tert-butyl ether | Used to dissolve gallbladder stones. Acronym: MTBE (05 Mar 2000) |
| methyl violet | Mixtures of tetra-, penta-, or pararosanilin which vary in shade of violet depending on the extent of methylation (designated R for reddish shades, B for bluish shades); the hexamethyl compound is known as crystal violet, the pentamenthyl compound as methyl violet 6B. As stains, methyl violet has many bacteriological, histological, and cytological applications. (05 Mar 2000) |
| methyl yellow | C6H5N:NC6H4N(CH3)2;a fat-soluble yellow dye (MW 225) that has hepatic carcinogenic action in experimental animals; used as an indicator of pH (red, at pH 2.9, yellow at pH 4.0). Synonym: dimethylaminoazobenzene, methyl yellow. (05 Mar 2000) |
| p,p'-dichlorodiphenyl methyl carbinol | A synthetic compound found effective as a miticide. Acronym: DMC (05 Mar 2000) |
| S-adenosyl-L-methionine-2-octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone-O-methyltransferase | <enzyme> Proposed pathway for final reaction in ubiquinone biosynthesis. Registry number: EC 2.1.1.- Synonym: 2-octaprenyl-3-methyl-5-hydroxy-6-methoxy-1,4-benzoquinone methyltransferase, ubig gene product, ubig protein (26 Jun 1999) |
| pyribenzyl methyl sulfate | 2-(hydroxymethyl)-1,1-dimethylpiperidinium methyl sulfate benzylate;an anticholinergic agent. Synonym: pyribenzyl methyl sulfate. (05 Mar 2000) |
| NADH-methyl viologen reductase | <enzyme> Fad-protein from rhodospirillum rubrum which also reduces methylene blue and 2,6-dichlorophenol-indophenol Registry number: EC 1.6.- (26 Jun 1999) |
| ng-nitroarginine methyl ester | <chemical> A non-selective inhibitor of nitric oxide synthase. It has been used experimentally to induce hypertension. Pharmacological action: enzyme inhibitors. (12 Dec 1998) |
| n-methyl-3,4-methylenedioxyamphetamine | <chemical> An n-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as mdma or ecstasy. Pharmacological action: adrenergic uptake inhibitors, hallucinogens, serotonin agents. Chemical name: 1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl- (12 Dec 1998) |
| N methyl D aspartate receptor | <physiology> Glutamate receptor sub type (see excitatory amino acids). N methyl D aspartate receptor channels seem to be potentiated by intracellular arachidonic acid. Acronym: NMDA (26 Mar 1998) |
| N-methyl, D-aspartic acid | n methyl D aspartate receptor |
| isoprenylcysteine methyl ester hydrolase | <enzyme> Acts on proteins post-translationally isoprenylated on a cysteine 3 amino acids in from the carboxy terminus, followed by carboxymethylation Registry number: EC 3.1.1.- Synonym: isoprenylcys methylase (26 Jun 1999) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|